AeroLeads people directory · profile

Li Yan Email & Phone Number

VP, Clinical Pharmacology at Candid Therapeutics
Location: San Francisco Bay Area, United States 10 work roles 4 schools
1 work email found @ngmbio.com LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email l****@ngmbio.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
VP, Clinical Pharmacology
Location
San Francisco Bay Area, United States
Company size

Who is Li Yan? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Li Yan is listed as VP, Clinical Pharmacology at Candid Therapeutics, a with 35 employees, based in San Francisco Bay Area, United States. AeroLeads shows a work email signal at ngmbio.com and a matched LinkedIn profile for Li Yan.

Li Yan previously worked as Senior Director, Head of Clinical Pharmacology at Spyre Therapeutics and Adjunct Professor at University Of The Pacific - Thomas J. Long School Of Pharmacy. Li Yan holds Phd, Bioengineering from University Of California, San Francisco.

Company email context

Email format at Candid Therapeutics

This section adds company-level context without repeating Li Yan's masked contact details.

{first_initial}{last}@ngmbio.com
86% confidence

AeroLeads found 1 current-domain work email signal for Li Yan. Compare company email patterns before reaching out.

Profile bio

About Li Yan

A strategic and collaborative leader with 17 years of experience in clinical pharmacology and pharmacometrics for biotherapeutics and small molecules from discovery to Phase 4. Goal-oriented with a problem-solving attitude to guide teamwork for troubleshooting and delivering multi-staged projects. Demonstrated ability to adhere to milestones and timelines. Extensive hands-on experience in translational TK/PK/PD and exposure-response modeling and simulation to support optimal drug candidate and dosage selection from preclinical through Phase 3 registrational trials. Track record of successful INDs, EOP2, BLAs, and MAAs. Achieved success in global filing, defense, and approval of 2 BLAs (UPLIZNA®, FASENRA®, and FASENRA® Self-Administration).Committed to professional development, I earned my PhD in a Joint Bioengineering Program from UCSF-UC Berkeley. Furthermore, my areas of expertise include: • Model-informed drug development (MIDD)• PK/PD and exposure-response analyses• Optimal study design and dosage selection• Global regulatory filing, defense and approval• Oncology, autoimmune, inflammatory, and rare diseases • Highly proficient in NONMEM, WinNonlin, R, etc.• Effective management of internal/external resources• Strong publication record: 50+ peer-reviewed publications & presentations

Listed skills include Clinical Study Design, Pharmacodynamics, Oncology, Pharmacokinetics, and 14 others.

Current workplace

Li Yan's current company

Company context helps verify the profile and gives searchers a useful next step.

Candid Therapeutics
Candid Therapeutics
VP, Clinical Pharmacology
California, United States
Website
Employees
35
AeroLeads page
10 roles · 20 years

Li Yan work experience

A career timeline built from the work history available for this profile.

Senior Director, Head Of Clinical Pharmacology

Current

San Francisco, Ca, Us

May 2024 - Present

Senior Director, Head Of Clinical Pharmacology And Dmpk

South San Francisco, Ca, Us

Built and led a high-performing Clinical Pharmacology & DMPK team. Oversaw and managed clinical pharmacology and DMPK-related activities from discovery to EOP2 for all NGM therapeutic areas. Provided extensive clinical pharmacology and DMPK leadership for the development and execution of the company-wide strategy.

Mar 2022 - Mar 2024

Senior Director, Clinical Pharmacology And Dmpk

Dublin, Ireland, Ie

Assumed expanded responsibilities following the acquisition. Grew the function by recruting & retaining top-performing talent. Collaborated with cross-functional teams to develop and execute Horizon's overall development strategy. Proactively evaluated risk/benefit and guided development decisions, including study design and optimal dose selections.

Oct 2021 - Mar 2022

Director, Clinical Pharmacology And Dmpk

Dublin, Ireland, Ie

In March 2021, Viela Bio was acquired by Horizon Therapeutics. Assumed responsibility for the post-acquisition initiatives by leading pharmacology activities across all Viela Bio legacy programs.

Mar 2021 - Sep 2021

Director, Head Of Clinical Pharmacology

Gaithersburg, Maryland, Us

Oversaw all clinical pharmacology activities for Viela Bio's portfolio, including study design, protocol development, study execution, data interpretation and reporting, and preparation of regulatory documents, interactions, and submissions. Thrived in an entrepreneurial organization by working with a highly hands-on and productive approach in a fast-paced, highly challenging, and collaborative environment. Led the clinical pharmacology effort for the BLA filing, defense, and approval of UPLIZNA (Inebilizumab)

Jul 2018 - Mar 2021

Senior Clinical Pharmacokineticist

Cambridge, Cambridgeshire, Gb

DMPK, clinical pharmacology, and pharmacometric lead for biotherapeutic products at various stages of research and clinical development. Oversaw all aspects of nonclinical and clinical pharmacology for multiple projects. Successfully led the clinical pharmacology effort for the EOP2, BLA filing, defense, and global approval of FASENRA (Benralizumab), and FDA approval of FASENRA self-administration

Aug 2012 - Jun 2018

Associate Scientist

Radnor, Pennsylvania, Us

Pharmacometrician responsible for population PK, PD, exposure-response modeling and simulation, and dosing regimen selection and optimization for small molecules and biologics across diverse therapeutic areas, including oncology, Alzheimer’s disease, cardiovascular diseases, erectile dysfunction and antiviral & biodefense.

2010 - 2012 ~2 yrs

Postdoctoral Fellow

San Francisco, California, Us

• Collaborated with UCSF physicians, conducted pharmacometrics modeling and simulation, and developed a piperaquine dosing strategy in Ugandan infants with malaria• Optimized enoxaparin dosing for factor Xa inhibition in gastric bypass patients.

2007 - 2010 ~3 yrs
4 education records

Li Yan education

Phd, Bioengineering

University Of California, San Francisco

Phd, Bioengineering

University Of California, Berkeley

Ms, Molecular, Cellular & Developmental Biology

University Of Colorado Boulder

Bs, Molecular Biology

Jilin University
FAQ

Frequently asked questions about Li Yan

Quick answers generated from the profile data available on this page.

What company does Li Yan work for?

Li Yan works for Candid Therapeutics.

What is Li Yan's role at Candid Therapeutics?

Li Yan is listed as VP, Clinical Pharmacology at Candid Therapeutics.

What is Li Yan's email address?

AeroLeads has found 1 work email signal at @ngmbio.com for Li Yan at Candid Therapeutics.

Where is Li Yan based?

Li Yan is based in San Francisco Bay Area, United States while working with Candid Therapeutics.

What companies has Li Yan worked for?

Li Yan has worked for Candid Therapeutics, Spyre Therapeutics, University Of The Pacific - Thomas J. Long School Of Pharmacy, Ngm Biopharmaceuticals, and Horizon.

How can I contact Li Yan?

You can use AeroLeads to view verified contact signals for Li Yan at Candid Therapeutics, including work email, phone, and LinkedIn data when available.

What schools did Li Yan attend?

Li Yan holds Phd, Bioengineering from University Of California, San Francisco.

What skills is Li Yan known for?

Li Yan is listed with skills including Clinical Study Design, Pharmacodynamics, Oncology, Pharmacokinetics, Clinical Pharmacology, Regulatory Submissions, Winnonlin, and Clinical Research.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.